Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer

The prognosis of most thyroid cancer patients is excellent, but for those with advanced or metastatic thyroid cancer, effective treatments are still lacking. Chimeric antigen receptor (CAR) T-cell therapy has gained remarkable achievements in hematologic malignancy but shown limited efficacy in soli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jing, Li, Deyu, Liu, Xingchen, Hei, Hu, Sun, Baoxi, Zhou, Dongmin, Zhou, Keshu, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494903/
https://www.ncbi.nlm.nih.gov/pubmed/36138444
http://dx.doi.org/10.1186/s40164-022-00311-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494903/
https://www.ncbi.nlm.nih.gov/pubmed/36138444
http://dx.doi.org/10.1186/s40164-022-00311-z

Ejemplares similares